Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics

    NEXT STORY
    Operational and Financial Results for the Period Ended September 30, 2020
    PREV STORY
    Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Philips signs agreement to create Taiwan’s first fully digitalized pathology department

    author_avatar
    NASDAQ Market News

    TRACON Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Corporate Update

    Strategic Licensing Collaboration with Janssen Expanded TRACON’s Oncology Portfolio and Validated Company’s Unique Clinical ...

    author_avatar
    NASDAQ Market News

    Vaxil Provides Pre-Clinical and Business Update

    author_avatar
    NASDAQ Market News